A-12
NDC 58264-0304, JUNIPERUS ASHEI POLLEN, JUNIPERUS VIRGINIANA POLLEN, TAMARIX GALLICA POLLEN, CUPRESSUS ARIZONICA POLLEN, TAXODIUM DISTICHUM POLLEN, JUNIPERUS MONOSPERMA POLLEN, JUNIPERUS PINCHOTII POLLEN, JUNIPERUS SCOPULORUM POLLEN, PINUS TAEDA POLLEN, PINUS STROBUS POLLEN, and PINUS ECHINATA POLLEN, solution, from DNA Labs, Inc..
- Product NDC
- 58264-0304
- Status
- Listed
- Labeler
- DNA Labs, Inc.
- Dosage form
- SOLUTION
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0304 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- JUNIPERUS ASHEI POLLEN30 [hp_X]/mL
- JUNIPERUS VIRGINIANA POLLEN30 [hp_X]/mL
- TAMARIX GALLICA POLLEN30 [hp_X]/mL
- CUPRESSUS ARIZONICA POLLEN30 [hp_X]/mL
- TAXODIUM DISTICHUM POLLEN30 [hp_X]/mL
- JUNIPERUS MONOSPERMA POLLEN30 [hp_X]/mL
- JUNIPERUS PINCHOTII POLLEN30 [hp_X]/mL
- JUNIPERUS SCOPULORUM POLLEN30 [hp_X]/mL
- PINUS TAEDA POLLEN30 [hp_X]/mL
- PINUS STROBUS POLLEN30 [hp_X]/mL
- PINUS ECHINATA POLLEN30 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58264-0304-1 | 58264030401 | 29.57 mL in 1 BOTTLE, GLASS (58264-0304-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58264-0304 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0304 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58264-0304. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.